"The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemi"...
VASCEPA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to VASCEPA or any of its components.
Last reviewed on RxList: 12/6/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Vascepa Information
- Vascepa Drug Interactions Center: icosapent ethyl oral
- Vascepa Side Effects Center
- Vascepa FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
Tips to keep it under control.